Deadline for submitting online application and all supplementary documents: June 1st 2019

The Fulbright Visiting Scholar Program (formerly ARSP) awards grants to foreign academics or professionals to conduct advanced research at U.S. institutions. Two categories of grants are offered under The Fulbright Visiting Scholar Program: Research Grants and Program and Curriculum Development Grants.

Research Grants: awards of 3 to 9 months are offered for selected university faculty professionals to conduct research in any academic discipline at a U.S. academic or research institution. Preference will be given to individuals with a doctorate degree, at least three years of university teaching experience, a productive scholarly record, and whose projects relate directly to their ongoing teaching and/or research responsibilities.

Program and Curriculum Development Grants: Awards of 3 to 6 months are offered for qualified university faculty to undertake a planned program of reading and research at a U.S. educational institution aimed at strengthening academic programs or curricula an the home institution.

HIV/AIDS: includes a special set of grants for scholars with proposals in HIV/AIDS-related research. Scholars in all academic disciplines are invited to formulate proposals with an HIV/AIDS focus. Candidates may apply either as research scholars or as program and curriculum development scholars.

Eligibility

  1. An intended applicant must be a citizen of Nigeria or a permanent resident, and should hold a valid Nigerian passport.
  2. In addition, applicants must have at least three (3) years of post-doctoral degree training or teaching experience at the time of application.

Application and Instructions

Applications are made online. The application and instructions can be found at https://iie.embark.com/apply/visitingscholars

Interested persons can get more information by sending an e-mail (with subject: Fulbright Visiting Scholar Inquiry) to CulturalAbuja@state.gov or CulturalLagos@state.gov

Visit webpage for more information here

Please follow and like us: